Vial Dermatology CRO announced that the associate professor of dermatology and rheumatology at Harvard Medical School and the vice chair of clinical trials and innovation at Brigham and Women's Hospital in Boston, Massachusetts, has joined its Scientific Advisory Board.
Joseph Merola, MD, MMSc, the associate professor of dermatology and rheumatology at Harvard Medical School and the vice chair of clinical trials and innovation at Brigham and Women's Hospital in Boston, Massachusetts, has joined its Scientific Advisory Board. TheVial Dermatology CRO announced the addition yesterday and said, “Merola will support the Vial CRO team, along with their sponsors, as they work to further advance the field of dermatology clinical research.”
Launched earlier this year, under the tag line, “The CRO Built for Sponsors”, the Vial Dermatology CRO promises higher quality and faster execution of trials powered by the Vial Clinic Network of over 35 Dermatology clinical research sites across the country. The Vial Scientific Advisory Board’s leading Dermatology KOLs will service sponsors in clinical strategy, regulatory strategy, trial design and overall clinical development plan pathways.
The scientific advisory board’s KOLs will service sponsors in clinical strategy, regulatory strategy, trial design, and overall clinical development plan pathways. Betsey Zbyszynski leads the Vial CRO team as the head of clinical operations. The team includes Jason Shuris as head of sales; Janet DuBois, MD, a dermatologist and principal researcher at DermResearch in Austin, Texas, as medical director; Justin Withers as head of dermatology; and Mamta Hunt as head of quality. The Vial CRO executive team have a combined 100-plus years of dermatology clinical trial experience.
“I’m excited to work with leading dermatologists to support Vial as they continue to grow and progress the field of dermatology through technology and streamlined clinical trials,” said Merola.
Merola is triple board certified in dermatology, internal medicine, and rheumatology and he earned his medical degree at New York University School of Medicine, followed by his Master of Medical Sciences degree at Harvard Medical School.
In addition to his roles at Harvard, Merola serves as vice chair for clinical trials, the director of the Clinical Unit for Research Innovation and Trials (CUReIT), director of the Center for Skin and Related Musculoskeletal Diseases and the associate program director for the Harvard Combined Internal Medicine-Dermatology Residency Training Program at Brigham and Women’s Hospital in Boston.
Other notable achievements from Merola are him being on the Medical Board of the National Psoriasis Foundation, the Board of the International Dermatology Outcome Measures Group, Steering Committee Member for GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), the Board of the Lupus Foundation of America and is on the Board and Founding President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN). Merola is also the president-elect of the Medical Dermatology Society. He is also a counselor for the International Eczema Council as well as the International Psoriasis Council.
Dr. Joseph Merola is announced as a member of vial’s scientific ad board. Published March 22, 2022. Accessed March 23, 2022. https://www.prnewswire.com/news-releases/dr-joseph-merola-is-announced-as-a-member-of-vials-scientific-ad-board-301508236.html